RxDoctor Payments Data

Samuel Lentz, MD

Gynecologic Oncology · Winston Salem, NCNPI 1154306702

Payments from drug & device makers

What this record shows

That places this record below the midpoint for gynecologic oncology clinicians in NC, where the typical reported total is $1,376.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$421,247in research payments, 2019–2025

Across 45 payments — averaging $9361.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$258K
  • Novocure Inc.$142K
  • Merck$17K
  • Pfizer$4K

How this compares

$0 in reported general payments places this provider in the 0th percentile of 52 gynecologic oncology providers in North Carolina.

See all gynecologic oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$18,023
Medicare patients
62
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron33$21,643
Estradiol13$894
Letrozole17$300
Cephalexin25$143
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$62

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →